MedTrace Logo

Clinical Performance Evaluation of KnowNow SARS-CoV-2 Test for the Detection of COVID-19 Antigen

NCT04733170 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2021-02-25

No results posted yet for this study

Summary

This is an international, multicentre, non-interventional, observational study to assess the clinical diagnostic performance of a rapid, point of care (POC) COVID-19 (SARS-CoV-2) antigen In vitro diagnostic (IVD), The KnowNow SARS-CoV-2 Rapid Antigen Test, using saliva samples when compared to reverse transcription polymerase chain reaction (RT-PCR) as the standard detection of COVID-19 infection.

Conditions

  • Covid19

Interventions

DIAGNOSTIC_TEST

KnowNow SARS-CoV-2 Rapid Antigen Test

KnowNow SARS-CoV-2 Rapid Antigen Test for the detection of Covid-19 in saliva, as compared to high sensitivity reverse transcription polymerase chain reaction (RT-PCR) of nasopharyngeal swabs as the reference test method

Sponsors & Collaborators

  • Vatic Ltd.

    lead INDUSTRY

Principal Investigators

  • Alex Sheppard, BA · Vatic Ltd.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-15
Primary Completion
2021-08-31
Completion
2021-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04733170 on ClinicalTrials.gov